Sg3 Management, LLC Astrazeneca PLC Transaction History

Sg3 Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$54.02 - $63.83 $4.84 Million - $5.72 Million	-89,600 Reduced 87.76%	12,500 $728,000
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $4.14 Million - $4.53 Million	74,600 Added 271.27%	102,100 $6.13 Million
Q2 2021 Aug 16, 2021	BUY	$48.42 - $60.18 $1.09 Million - $1.35 Million	22,500 Added 450.0%	27,500 $1.65 Million
Q1 2021 May 17, 2021	BUY	$47.16 - $54.44 $235,799 - $272,200	5,000 New	5,000 $249,000
Q3 2020 Nov 13, 2020	SELL	$53.07 - $61.1 $742,980 - $855,400	-14,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $603,400 - $774,340	14,000 New	14,000 $740,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.